Found: 11
Select item for more details and to access through your institution.
Treatment intensification for metastatic prostate cancer: New treatment landscapes in androgen deprivation‐based therapy.
- Published in:
- Cancer Communications, 2022, v. 42, n. 8, p. 683, doi. 10.1002/cac2.12340
- By:
- Publication type:
- Article
Metastatic Urothelial Carcinoma: Have We Take the Road to the Personalized Medicine?
- Published in:
- 2022
- By:
- Publication type:
- Editorial
Antibody-Drug Conjugates in Urothelial Carcinoma: A New Therapeutic Opportunity Moves from Bench to Bedside.
- Published in:
- Cells (2073-4409), 2022, v. 11, n. 5, p. 803, doi. 10.3390/cells11050803
- By:
- Publication type:
- Article
How to Improve the Quality of Life of Patients with Prostate Cancer Treated with Hormone Therapy?
- Published in:
- Research & Reports in Urology, 2023, v. 15, p. 9, doi. 10.2147/RRU.S350793
- By:
- Publication type:
- Article
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study.
- Published in:
- Minerva Urology & Nephrology, 2022, v. 74, n. 6, p. 703, doi. 10.23736/S2724-6051.22.04701-2
- By:
- Publication type:
- Article
prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide.
- Published in:
- Minerva Urology & Nephrology, 2021, v. 73, n. 6, p. 803, doi. 10.23736/S2724-6051.21.04186-2
- By:
- Publication type:
- Article
association of statin use and oncological outcomes in patients with first diagnosis of T<sub>1</sub> high grade non-muscle invasive urothelial bladder cancer: results from a multicenter study.
- Published in:
- Minerva Urology & Nephrology, 2021, v. 73, n. 6, p. 796, doi. 10.23736/S2724-6051.20.04076-X
- By:
- Publication type:
- Article
Prognostic factors in metastatic castration resistant prostate cancer patients treated with radium-223: a retrospective study.
- Published in:
- Minerva Pediatrics, 2022, v. 74, n. 6, p. 703, doi. 10.23736/S2724-6051.22.04701-2
- By:
- Publication type:
- Article
Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel.
- Published in:
- Acta Oncologica, 2017, v. 56, n. 4, p. 555, doi. 10.1080/0284186X.2016.1260772
- By:
- Publication type:
- Article
Short-Term Safety and Psychosocial Impact of the BNT162b2 mRNA COVID-19 Vaccine in Cancer Patients—An Italian Single-Center Experience.
- Published in:
- Biomedicines, 2023, v. 11, n. 1, p. 165, doi. 10.3390/biomedicines11010165
- By:
- Publication type:
- Article
Navigating the ICI Combination Treatment Journey: Patterns of Response and Progression to First-Line ICI-Based Combination Treatment in Metastatic Renal Cell Carcinoma.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 2, p. 307, doi. 10.3390/jcm13020307
- By:
- Publication type:
- Article